| Year |
Citation |
Score |
| 2020 |
Youssef Y, Karkhanis V, Chan WK, Jeney F, Canella A, Zhang X, Sloan S, Prouty A, Helmig-Mason J, Tsyba L, Hanel W, Zheng X, Zhang P, Chung JH, Lucas DM, ... ... Han R, et al. Transducin β-like protein 1 controls multiple oncogenic networks in diffuse large B-cell lymphoma. Haematologica. PMID 33054136 DOI: 10.3324/haematol.2020.268235 |
0.384 |
|
| 2019 |
Nomura M, Rainusso N, Lee YC, Dawson B, Coarfa C, Han R, Larson JL, Shuck R, Kurenbekova L, Yustein JT. Tegavivint and the β-catenin/ALDH Axis in Chemotherapy-Resistant and Metastatic Osteosarcoma. Journal of the National Cancer Institute. PMID 30793158 DOI: 10.1093/Jnci/Djz026 |
0.316 |
|
| 2018 |
Bailey C, Romero M, Han R, Larson J, Becher O, Lee D, Monje M, Gopalakrishnan V, Zaky W, Chandra J. IMMU-19. LSD1 MODULATES NK CELL IMMUNOTHERAPY THROUGH AN ONCO-IMMUNOGENIC GENE SIGNATURE IN DIPG Neuro-Oncology. 20: i102-i102. DOI: 10.1093/Neuonc/Noy059.335 |
0.306 |
|
| 2016 |
Han R, Huang S, Bao Y, Liu X, Peng X, Chen Z, Wang Q, Wang J, Zhang Q, Wang T, Zheng D, Yang W. Upregulation of SOX4 antagonizes cellular senescence in esophageal squamous cell carcinoma. Oncology Letters. 12: 1367-1372. PMID 27446439 DOI: 10.3892/ol.2016.4799 |
0.322 |
|
| 2016 |
Zhao JK, Wu M, Kim CH, Jin ZY, Zhou JY, Han RQ, Yang J, Zhang XF, Wang XS, Liu AM, Gu X, Su M, Hu X, Sun Z, Li G, et al. Jiangsu Four Cancers Study: a large case-control study of lung, liver, stomach, and esophageal cancers in Jiangsu Province, China. European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (Ecp). PMID 27275735 DOI: 10.1097/Cej.0000000000000262 |
0.317 |
|
| 2016 |
Li L, Wang Y, Peng T, Zhang K, Lin C, Han R, Lu C, He Y. Metformin restores crizotinib sensitivity in crizotinib-resistant human lung cancer cells through inhibition of IGF1-R signaling pathway. Oncotarget. PMID 27144340 DOI: 10.18632/oncotarget.9120 |
0.3 |
|
| 2016 |
Shang Z, Li Y, Hsu I, Zhang M, Tian J, Wen S, Han R, Messing EM, Chang C, Niu Y, Yeh S. Targeting estrogen/estrogen receptor alpha will enhance Bacillus Calmette-Guerin efficacy in bladder cancer. Oncotarget. PMID 27092883 DOI: 10.18632/Oncotarget.8756 |
0.368 |
|
| 2016 |
Yeo SY, Itahana Y, Guo AK, Han R, Iwamoto K, Nguyen HT, Bao Y, Kleiber K, Wu YJ, Bay BH, Voorhoeve M, Itahana K. Transglutaminase 2 contributes to a TP53-induced autophagy program to prevent oncogenic transformation. Elife. 5. PMID 26956429 DOI: 10.7554/eLife.07101 |
0.35 |
|
| 2015 |
Shang Z, Li Y, Zhang M, Tian J, Han R, Shyr CR, Messing E, Yeh S, Niu Y, Chang C. Anti-androgen therapy with Hydroxyflutamide or androgen receptor degradation enhancer ASC-J9® enhances BCG efficacy to better suppress bladder cancer progression. Molecular Cancer Therapeutics. PMID 26264279 DOI: 10.1158/1535-7163.Mct-14-1055-T |
0.428 |
|
| 2015 |
Sun E, Zhang W, Wang L, Wang A, Ma C, Lei M, Zhou X, Sun Y, Lu B, Liu L, Han R. Down-regulation of Sphk2 suppresses bladder cancer progression. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. PMID 26224479 DOI: 10.1007/s13277-015-3818-z |
0.459 |
|
| 2015 |
Xiao P, Sun LL, Wang J, Han RL, Ma Q, Zhong DS. LKB1 gene inactivation does not sensitize non-small cell lung cancer cells to mTOR inhibitors in vitro. Acta Pharmacologica Sinica. PMID 26027660 DOI: 10.1038/aps.2015.19 |
0.362 |
|
| 2015 |
Sun E, Fan X, Wang L, Lei M, Zhou X, Liu C, Lu B, Nian X, Sun Y, Han R. Recombinant hIFN-α2b-BCG inhibits tumor growth in a mouse model of bladder cancer. Oncology Reports. 34: 183-94. PMID 25998552 DOI: 10.3892/or.2015.3985 |
0.308 |
|
| 2015 |
Sun E, Nian X, Liu C, Fan X, Han R. Construction of recombinant human IFNα-2b BCG and its antitumor effects on bladder cancer cells in vitro. Genetics and Molecular Research : Gmr. 14: 3436-49. PMID 25966110 DOI: 10.4238/2015.April.15.7 |
0.301 |
|
| 2013 |
Chen HY, Yang YM, Han R, Noble M. MEK1/2 inhibition suppresses tamoxifen toxicity on CNS glial progenitor cells. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 15069-74. PMID 24048837 DOI: 10.1523/Jneurosci.2729-13.2013 |
0.643 |
|
| 2008 |
Han R, Yang YM, Dietrich J, Luebke A, Mayer-Pröschel M, Noble M. Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system. Journal of Biology. 7: 12. PMID 18430259 DOI: 10.1186/Jbiol69 |
0.667 |
|
| 2006 |
Dietrich J, Han R, Yang Y, Mayer-Pröschel M, Noble M. CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo. Journal of Biology. 5: 22. PMID 17125495 DOI: 10.1186/Jbiol50 |
0.636 |
|
| Show low-probability matches. |